Susquehanna International Group
VERA icon

Susquehanna International Group’s Vera Therapeutics VERA Stock Holding History

Susquehanna International Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
26,300
-2,400
-8% -$103K ﹤0.01% 7750
2025
Q4 		$1.45M Sell
28,700
-62,300
-68% -$2.21M ﹤0.01% 6324
2025
Q3 		$2.64M Sell
91,000
-92,100
-50% -$2.13M ﹤0.01% 5218
2025
Q2 		$4.31M Buy
183,100
+142,100
+347% +$3.2M ﹤0.01% 4263
2025
Q1 		$985K Buy
41,000
+25,100
+158% +$807K ﹤0.01% 7301
2024
Q4 		$672K Sell
15,900
-66,100
-81% -$2.93M ﹤0.01% 7926
2024
Q3 		$3.62M Buy
82,000
+30,200
+58% +$1.15M ﹤0.01% 4188
2024
Q2 		$1.87M Sell
51,800
-15,900
-23% -$631K ﹤0.01% 5216
2024
Q1 		$2.92M Buy
67,700
+51,200
+310% +$1.82M ﹤0.01% 4574
2023
Q4 		$254K Buy
+16,500
New +$210K ﹤0.01% 10185
2023
Q3 		– Sell
-12,600
Closed -$202K – 13060
2023
Q2 		$202K Sell
12,600
-19,000
-60% -$172K ﹤0.01% 10244
2023
Q1 		$245K Buy
+31,600
New +$244K ﹤0.01% 10166

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's VERA Position: Q1 2026 in Review

Susquehanna International Group reduced its Vera Therapeutics (VERA) stake by 32% in Q1 2026, selling an estimated $2.4M and leaving 121,020 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #4278.

Susquehanna International Group first reported a position in VERA in Q1 2023 and has held it in 13 quarters since. The position peaked at $8.95M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Susquehanna International Group held 121,020 shares of Vera Therapeutics worth $4.87M as of Q1 2026.
  • Susquehanna International Group sold 55,664 Vera Therapeutics shares in Q1 2026, an estimated $2.4M.
  • Vera Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4278 holding.
  • Susquehanna International Group first reported a position in Vera Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Susquehanna International Group's Vera Therapeutics position peaked at $8.95M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.